These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study. Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer]. Lind P; Igerc I; Kohlfürst S Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998 [TBL] [Abstract][Full Text] [Related]
4. [Combined radioiodine (I131) treatment and radio-guided surgery for recurrent cervical well-differentiated thyroid cancer]. Schachter P; Shimonov M; Lorberboim M Harefuah; 2005 Mar; 144(3):168-72, 232, 231. PubMed ID: 15844454 [TBL] [Abstract][Full Text] [Related]
5. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Jarzab B; Handkiewicz-Junak D; Wloch J Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322 [TBL] [Abstract][Full Text] [Related]
7. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma. Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760 [TBL] [Abstract][Full Text] [Related]
9. Follow-up of differentiated thyroid carcinoma. Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026 [TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy in differentiated thyroid carcinoma. Salvatori M; Rufini V; Garganese MC; Di Giuda D Rays; 2000; 25(2):221-38. PubMed ID: 11370540 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. Perros P J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003 [TBL] [Abstract][Full Text] [Related]
12. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]. Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ; Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757 [TBL] [Abstract][Full Text] [Related]
13. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638 [TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy for papillary and follicular thyroid carcinoma. Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131. Reiners C; Luster M; Lassmann M J Endocrinol Invest; 1999; 22(11 Suppl):17-24. PubMed ID: 10727001 [TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer in infants and adolescents after Chernobyl. Reiners C; Demidchik YE; Drozd VM; Biko J Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Vassilopoulou-Sellin R; Schultz PN; Haynie TP Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396 [TBL] [Abstract][Full Text] [Related]